Skip to search formSkip to main contentSkip to account menu
A Novel Coronavirus from Patients with Pneumonia in China, 2019
TLDR
Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
View on PubMed
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
View on Elsevier
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.
This study describes results of PCR and viral RNA testing for SARS-CoV-2 in bronchoalveolar fluid, sputum, feces, blood, and urine specimens from patients with COVID-19 infection in China to identify…
View on PubMed
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
View on Elsevier
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
TLDR
It is proposed that the immunomodulatory effect of hydroxychloroquine also may be useful in controlling the cytokine storm that occurs late-phase in critically ill SARS-CoV-2 infected patients.
View PDF
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
TLDR
It is found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but ferrets and cats are permissive to infection and Additionally, cats are susceptible to airborne transmission.
View on Publisher
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
TLDR
In isolation of four human-origin monoclonal antibodies from a convalescent patient, all of which display neutralization abilities, a therapeutic study in a mouse model validated that these antibodies can reduce virus titers in infected lungs.
View on Science
High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses
TLDR
Seven compounds were identified as broad-spectrum inhibitors according to their strong inhibition of replication by four CoVs in vitro at low-micromolar concentrations and emetine blocked MERS-CoV entry according to pseudovirus entry assays and lycorine protected BALB/c mice against HCoV-OC43-induced lethality by decreasing viral load in the central nervous system.
View on Publisher
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
View on Elsevier
The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists
TLDR
It is revealed that the ORF 4a protein of MERS-CoV has the most potential to counteract the antiviral effects of IFN via the inhibition of both the interferon production and ISRE promoter element signaling pathways.
View on Springer
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License